The Importance of SDPA Fall Conference for Physician Assistants
Renata Block, MMS, PA-C., explains the importance of The Society of Dermatology Physician Assistants (SDPA) 2022 Conference.
Updates on Psoriasis and Related Comorbidities
Shanna Miranti, MPAS, PA-C, shares highlights from her shared session at the 2022 SDPA Conference.
Updates on Treating Warts, Molluscum Contagiosum, and Other Pediatric Conditions
Shanna Miranti, MPAS, PA-C, shares highlights from her first session at the 2022 SDPA Conference in Miami, Florida.
Pointers With Portela: Questionable Beauty Hacks
In this week’s Pointers with Dr Portela, the 208SkinDoc reacts to questionable online beauty hacks.
Safety and JAK Inhibitors
Experts share clinical insights boxed warning for the JAK inhibitor drug class.
Case 2: Patient and Provider Educational Needs
Dr Mark Lebwohl provides insight into the educational needs of both patients and providers surround the utilization of spesolimab and its importance in the management of patients with generalized pustular psoriasis.
Case 2: Changing the Treatment Paradigm
Mark G. Lebwohl, MD, comments on the clinical implications of the recent approval of spesolimab for the treatment of generalized pustular psoriasis.
The Impact of Itch on Patients With Atopic Dermatitis
Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, explore the burden of itch in atopic dermatitis, and why JAK inhibitors may be able to provide relief.
Case 2: 64-Year-Old Female With a Long History of Plaque Psoriasis
An expert in dermatology presents the case of a 64-year-old female with a long history of plaque psoriasis, focusing on her disease severity and age-related management considerations.
Managing Candidiasis Associated With IL-17 Inhibitors in Plaque Psoriasis
Expert dermatologists discuss the risk of candidiasis with IL-17 inhibitors when managing plaque psoriasis and how to manage candidiasis.
Using Bimekizumab to Manage Plaque Psoriasis
Drs Mark G. Lebwohl and Alice B. Gottlieb discuss the novel mechanism of bimekizumab and how it can change the treatment landscape for plaque psoriasis.
Pointers With Portela: RoC Fill + Treat Review
In this week’s Pointers with Dr Portela, the 208SkinDoc reviews RoC's Fill + Treat Serum.
Muneeb Shah, DO, Discusses What it Means to Have Healthy Skin
November kicks off National Healthy Skin Month, presenting an opportunity to learn new habits for healthier skin.
David Light, CEO of Valisure, Reviews Petition Sent to FDA Regarding Benzene Contamination
Valisure, an independent laboratory, recently sent a Citizen's Petition to the FDA regarding high levels of benzene found in dry shampoo products.
Case 1: Treatment and Disease Management Goals
Goals of generalized pustular psoriasis treatment are reviewed by Dr Mark Lebwohl, where he comments on the need to consider patient disease severity and comorbidities.
Case 1: Treatment and Disease Management Challenges
Dr Mark Lebwohl comments on the treatment and management considerations for a patient suffering from severe generalized pustular psoriasis, highlighting the inefficiency of systemic steroids in the management of this condition.
Oral Agents for the Treatment of Atopic Dermatitis
Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, talk about the use of oral systemic agents and what they’ve learned about the patient experience from the use of these agents.
The Benefits of Topical Ruxolitinib
Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, examine the clinical context for the approval of topical ruxolitinib and its role in the treatment armamentarium.
Case 1: 28-Year-Old Female Patient With Psoriasis
Mark G. Lebwohl, MD, introduces the case of a 28-year-old female nurse with a long history of psoriasis, commenting on her past medical history and initial presentation.
Role of IL-17 Inhibitor Durability in Plaque Psoriasis
Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss the durability of IL-17 inhibitors in managing plaque psoriasis.
